摘要
从控制同种异体骨在临床使用时存在的潜在风险的角度,探讨对该类产品进行风险控制的措施和质量管理的重点关注环节,并汇总介绍了国内现有生产企业在质量管理体系方面存在的主要问题。
From the view of the potential risks of allogeneic bone products in clinical use. the key aspects of risk control and quality management for these products are discussed, as well as the general problems existing in the quality management system of their production enterprises in China are briefly introuduced.
出处
《中国医疗器械杂志》
CAS
2012年第5期365-369,共5页
Chinese Journal of Medical Instrumentation